Nicholas Lydon, Director at ANAPTYSBIO INC (ANAB), bought 220,291 shares at $15.00 ($250K) on 2017-01-31, disclosed to the SEC on 2017-01-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 203,625 | $0 | 0.0% |
| 2 | $15.00 | 16,666 | $250K | 100.0% |
| Total | $1.13 avg | 220,291 | $250K | 100% |
| Filing → |
| BPMC | SELL | 2020-07-08 | $4.1M | — | Filing → |
| BPMC | SELL | 2020-07-06 | $661K | — | Filing → |
| BPMC | SELL | 2020-06-25 | $32K | — | Filing → |